Glenmark Pharmaceuticals Limited

NSE: GLENMARKHealthcareLot size: 375

Glenmark Pharmaceuticals Limited Open Interest & PCR Analysis

₹2300.00Updated 28 Oct 2026, 03:30 pm IST
PCR
0.52Bearish signal
Max Pain
₹2260Spot above by ₹40
Total CE OI
1.09MCall writers
Total PE OI
566KPut writers
OI Buildup Signal
Neutral
Price movement < 0.3% threshold
Put-Call Ratio Gauge
0 — Bearish1.0 — Neutral2.0+ — Bullish
AI AnalysisGenerated daily after market close · AI-powered

OI Buildup Pattern

Open‑interest shows a neutral buildup, with price flat at ₹2,300 and total CE OI unchanged at 1,087,875 contracts. Call OI stands at 5,65,875 contracts, putting puts at the balance, so directional exposure is roughly even. With price and OI static, the market holds its current stance rather than building aggressive longs or shorts.

Put-Call Ratio

The put‑call ratio sits at 0.52, indicating call‑side dominance in the options market. The ratio of 0.52 reflects that for every put contract there are roughly two call contracts outstanding. Compared with yesterday’s 0.593, the ratio has narrowed, suggesting that call writers are adding contracts or put buyers are reducing exposure and the shift points to a modest reduction in bearish positioning.

Futures OI

Futures open interest registers zero change for the current expiry, indicating no net addition or liquidation of positions. Such a flat futures OI profile complements the neutral spot OI environment and implies that market participants are not altering their directional bets still in the underlying at present, investors are still maintaining their exposure today.

Data Summary

Overall, the unchanged total CE open interest of 1,087,875 contracts, paired with a 0.52 put‑call ratio and stagnant futures OI, underscores a market that is maintaining its existing positioning without significant new long or short buildup for this expiry. Investors appear to be waiting for a catalyst before adjusting their exposure, resulting in a quiet trading atmosphere today.

Data as of 2026-10-28

Frequently Asked Questions

What is Glenmark Pharmaceuticals Limited PCR (Put-Call Ratio) today?
Glenmark Pharmaceuticals Limited's current PCR is 0.52. A PCR above 1.2 is considered bullish (more put writing = floor support); below 0.8 is bearish; 0.8–1.2 is neutral. Glenmark Pharmaceuticals Limited's PCR of 0.52 indicates bearish sentiment.
What is Glenmark Pharmaceuticals Limited OI buildup type today?
Glenmark Pharmaceuticals Limited is currently showing neutral positioning with no significant directional bias. This is determined by comparing today's price change direction with the direction of total OI change — using the standard F&O buildup classification framework.
What is total CE and PE open interest for Glenmark Pharmaceuticals Limited?
Glenmark Pharmaceuticals Limited has total CE (call) OI of 1087875 contracts and total PE (put) OI of 565875 contracts for the nearest expiry. The PCR is 0.52.
How is open interest analysis useful for Glenmark Pharmaceuticals Limited trading?
OI analysis for Glenmark Pharmaceuticals Limited helps identify institutional positioning. High CE OI at a strike = call writers defending that level (resistance). High PE OI = put writers defending that level (support). The buildup type tells you whether smart money is building fresh positions (bullish/bearish) or exiting existing ones.
What is the max pain for Glenmark Pharmaceuticals Limited?
Glenmark Pharmaceuticals Limited's max pain is ₹2,260 — the strike price where option writers (sellers) collectively suffer the least financial loss at expiry. The current spot price vs max pain deviation guides near-term directional bias into expiry.